PRRX1 and cancer: It remains to be investigated whether PRRX1 has a transcription-independent role in regulating cancer microenvironment, such as cancer-associated fibroblasts [32], and how PRRX1-mediated regulation of NHEJ efficiency could influence responses to combination therapies, particularly those involving immune checkpoint inhibitors.